Stocks and Investing
Stocks and Investing
Thu, February 18, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John Pitzer Maintained (SNPS) at Buy with Increased Target to $300 on, Feb 18th, 2021
John Pitzer of Credit Suisse, Maintained "Synopsys, Inc." (SNPS) at Buy with Increased Target from $265 to $300 on, Feb 18th, 2021.
John has made no other calls on SNPS in the last 4 months.
There are 4 other peers that have a rating on SNPS. Out of the 4 peers that are also analyzing SNPS, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vivek Arya of "B of A Securities" Downgraded from Strong Buy to Hold on, Monday, January 11th, 2021
These are the ratings of the 3 analyists that currently disagree with John
- Mitch Steves of "RBC Capital" Maintained at Buy with Increased Target to $330 on, Tuesday, February 16th, 2021
- Pradeep Ramani of "UBS" Maintained at Strong Buy with Increased Target to $330 on, Tuesday, February 16th, 2021
- Gary Mobley of "Wells Fargo" Maintained at Buy with Increased Target to $310 on, Wednesday, February 10th, 2021
Contributing Sources